Generic Femara ( Letrozole )

Buy Generic Femara (Letrozole) without prescription at Canadian Pharmacy

At our pharmacy, you can buy Femara without a prescription, with discreet and anonymous packaging delivered within 5-14 days across Canada.

What is Femara?

Femara is a hormonal therapy used to treat certain types of breast cancer in postmenopausal women. The active ingredient is letrozole, which belongs to a class of drugs called aromatase inhibitors. After menopause, the ovaries stop making estrogen. But the body still produces a small amount from androgens through an enzyme called aromatase. That leftover estrogen can feed hormone receptor-positive breast cancer cells. Letrozole blocks the aromatase enzyme. The result is a deep drop in estrogen levels, starving the cancer cells and slowing or stopping tumour growth.

This is not chemotherapy. It is a daily pill that changes the body's hormone environment. The effect is measured over months, not days. Femara is used after surgery to lower the risk of recurrence, as first-line treatment for advanced breast cancer, and sometimes after tamoxifen has stopped working. The standard dose is one 2.5 mg tablet taken once daily, every day, for years. It is a long-term commitment. The full benefit builds over 5 years or more of continuous treatment. Femara is manufactured by Novartis and is available as a generic under the name letrozole.

Mechanism and Pharmacology

Letrozole is a potent, non-steroidal aromatase inhibitor. It binds reversibly to the aromatase enzyme, which converts androgens like androstenedione and testosterone into estrogens, mainly estrone and estradiol. In postmenopausal women, this peripheral conversion in fat, muscle, and liver is the main source of estrogen. By blocking the enzyme, letrozole suppresses blood estradiol levels by more than 90 percent within a few days. In premenopausal women, the ovaries produce so much estrogen that this blockade is overwhelmed, so letrozole is only used after menopause. In men, it is occasionally used off-label to manage estrogen excess from testosterone therapy, but the official indication is breast cancer.

After oral administration, letrozole is well absorbed, with peak plasma levels reached in about 1 to 2 hours. Food does not significantly affect the total amount absorbed, so it can be taken with or without food. The drug is extensively metabolized in the liver, primarily by CYP2A6 and CYP3A4. The half-life is about 2 days, allowing for once-daily dosing. Steady-state is reached in about 2 to 6 weeks. The drug is eliminated mainly in the urine as metabolites. Mild to moderate liver or kidney impairment does not require dose adjustment, but caution is advised in severe liver disease. Letrozole does not significantly inhibit or induce cytochrome P450 enzymes at therapeutic doses, so it has relatively few drug interactions compared to many other cancer drugs.

How to Use Femara

Take one 2.5 mg tablet once daily, at the same time each day. You can take it with or without food. Swallow the tablet whole with water. Do not crush or chew it. The dose is always 2.5 mg daily for the approved indications; there is no dose titration. If you miss a dose, take it as soon as you remember, unless it is almost time for the next dose. In that case, skip the missed one and continue with your regular schedule. Do not double up. Missing an occasional dose is not usually dangerous, but consistency matters for long-term benefit.

Femara is usually taken for 5 years as adjuvant therapy, and sometimes longer. For metastatic breast cancer, it is continued as long as the cancer responds and side effects are manageable. Do not stop taking it without discussing with your oncologist. Stopping early reduces the benefit. Your doctor will monitor your bone density because long-term estrogen suppression weakens bones. You may need a bone density scan before starting and periodically during treatment. Calcium and vitamin D supplements are often recommended. If you develop joint pain or stiffness, tell your doctor. This is common and can usually be managed with exercise, analgesics, or sometimes a switch to a different aromatase inhibitor. Regular blood tests are not usually needed for letrozole itself, but your doctor will monitor your overall health and may check your cholesterol, as estrogen suppression can raise lipid levels.

Side Effects of Femara

The side effects of letrozole are largely the consequences of estrogen deprivation. The most common complaint is joint pain and stiffness. It can affect the hands, wrists, knees, and back, and for some women it is severe enough to make exercise difficult. The pain often improves over time, and regular physical activity, such as walking or swimming, helps. Acetaminophen or ibuprofen can be used, but check with your doctor. Some women find that switching to a different aromatase inhibitor, like anastrozole or exemestane, relieves the joint pain. Hot flashes and night sweats are very common, because the body is being pushed into a deeper menopause. Dressing in layers, keeping the bedroom cool, and avoiding triggers like caffeine and alcohol can help. Vaginal dryness and decreased libido are also frequent. Water-based lubricants and vaginal moisturizers provide some relief. For women with severe vaginal symptoms, a low-dose topical estrogen may be considered, but this should be discussed with the oncologist, as even topical estrogen can be absorbed into the bloodstream.

Osteoporosis and bone fractures are a serious long-term risk. Letrozole reduces bone density by lowering estrogen. Your doctor will monitor your bone density and may prescribe a bisphosphonate like alendronate or a newer agent like denosumab if your bones show significant thinning. Weight-bearing exercise, calcium, and vitamin D are essential. Fatigue is common and can be persistent. Some women also report mood changes, including mild depression or irritability. These usually settle over time. Hair thinning may occur, though it is usually mild. Letrozole can raise cholesterol levels, so your lipid profile may be checked periodically. Rare but serious side effects include liver toxicity, presenting with jaundice or abdominal pain, and severe skin reactions. If you notice yellowing of your skin or eyes, stop the drug and call your doctor.

High-Risk Groups (Elderly, Pregnancy)

Pregnancy. Letrozole is absolutely contraindicated during pregnancy. It can cause fetal harm and should never be used by a woman who is pregnant or may become pregnant. It is only indicated for postmenopausal women, so pregnancy is not usually a relevant concern. However, if a premenopausal woman somehow takes it, or if a postmenopausal woman becomes pregnant through assisted reproduction, the drug must be stopped immediately. Breastfeeding is not relevant for postmenopausal women, but letrozole should not be used while breastfeeding. It may pass into breast milk and affect the infant.

Elderly women are the primary users of letrozole, and the 2.5 mg dose is the same regardless of age. Older patients are more likely to have osteoporosis already, so bone density monitoring is especially important. They may also be more sensitive to joint pain and fatigue. No dose adjustment is needed for age alone. Patients with moderate to severe liver impairment should use letrozole with caution, and liver function should be checked. Kidney impairment does not require a dose change. Women with severe osteoporosis or a history of fragility fractures should be started on bone-protective therapy early, as the drug will worsen bone loss. Those with a history of heart disease should be aware that aromatase inhibitors may slightly increase the risk of cardiovascular events, though the absolute risk is small. Regular monitoring of blood pressure and lipids is sensible.

Interaction With Activities (Driving, Alcohol)

Letrozole does not cause drowsiness, dizziness, or cognitive impairment. You can drive and operate machinery normally. If you experience severe fatigue or joint pain that distracts you, use caution, but the drug itself does not affect alertness. Alcohol has no direct interaction with letrozole. You can drink in moderation. However, alcohol can worsen hot flashes, disrupt sleep, and contribute to bone loss. It is best to keep alcohol intake light, especially if you are trying to manage side effects. Heavy drinking is discouraged, particularly if you have liver concerns or are taking other medications that affect the liver.

Drug Interactions

Letrozole has relatively few significant drug interactions. It is metabolized by CYP2A6 and CYP3A4, but at therapeutic doses it does not substantially inhibit or induce any major drug-metabolizing enzymes. Tamoxifen, another hormonal therapy, should not be used together with letrozole in the adjuvant setting. Tamoxifen can reduce the effectiveness of letrozole when given simultaneously, and the combination offers no benefit over either drug alone. The two are used sequentially, not together. Estrogen-containing products, including hormone replacement therapy and some vaginal estrogen preparations, counteract the effect of letrozole and should be avoided. If vaginal estrogen is needed, your oncologist will discuss the risks and benefits. Rifampin, a strong CYP3A4 inducer, can lower letrozole levels, but the clinical significance is uncertain. No dose adjustment is usually made. Always tell your oncologist and pharmacist about every medication, supplement, and herbal product you take, including over-the-counter drugs. In particular, discuss any calcium, vitamin D, or bone-protective supplements you are using, as these are commonly recommended alongside letrozole but should be part of a coordinated plan.

Alternative Options

Letrozole is one of three aromatase inhibitors. Anastrozole (Arimidex) and exemestane (Aromasin) are the other two. All three reduce estrogen to very low levels and are similarly effective, but they have slightly different side effect profiles. Some women who cannot tolerate the joint pain from letrozole do better on anastrozole or exemestane, and vice versa. Tamoxifen is a different kind of hormonal therapy. It blocks estrogen receptors rather than reducing estrogen production. Tamoxifen is still a standard option, especially in premenopausal women, and it has a different side effect profile, including a small risk of endometrial cancer and blood clots. For postmenopausal women, aromatase inhibitors are generally more effective than tamoxifen in reducing the risk of recurrence, but the choice depends on the individual woman's bone health, cardiovascular risk, and tolerance. For advanced breast cancer, fulvestrant is an injectable estrogen receptor antagonist used after aromatase inhibitors stop working. CDK4/6 inhibitors like palbociclib, ribociclib, and abemaciclib are often added to an aromatase inhibitor as first-line therapy for metastatic hormone receptor-positive breast cancer, and they significantly improve progression-free survival. Your oncologist will choose the best regimen based on your specific cancer characteristics and overall health.

INN, Brand Names, and Classification in Canada

INN (International Nonproprietary Name): Letrozole
Available brand names in Canada: Femara, and generic letrozole
ATC code: L02BG04
Forms and strengths: Film-coated tablets 2.5 mg. The standard dose is 2.5 mg once daily.
Manufacturers: Novartis Pharmaceuticals Canada Inc. (Femara), and diverse generic manufacturers including Apotex Inc., Teva Canada Limited, and Sandoz Canada Inc.
Registration status in Canada: Registered
Classification: Prescription (Rx)

Frequently Asked Questions

How long will I need to take Femara?
For adjuvant treatment after surgery, the usual duration is 5 years, and some women continue for up to 10 years based on their risk of recurrence. For metastatic breast cancer, it is taken as long as it keeps the cancer under control and side effects are tolerable. Your oncologist will tell you the expected duration for your situation.

Why does Femara cause joint pain?
Estrogen helps keep joints lubricated and reduces inflammation. When letrozole lowers estrogen to near zero, many women feel stiffness and pain in their hands, knees, and back. The pain often improves over time. Staying active, stretching, and using mild pain relievers can help. If the pain is severe, your doctor may switch you to a different aromatase inhibitor.

Will I lose my hair?
Hair thinning is uncommon with letrozole, but some women notice mild thinning or changes in hair texture. It is usually not the dramatic hair loss seen with chemotherapy. If it bothers you, talk to your doctor.

Can I take Femara with my calcium and vitamin D?
Yes. Calcium and vitamin D are often recommended to protect your bones while on letrozole. Your doctor will tell you how much to take. If you are also prescribed a bisphosphonate or another bone-protective drug, follow the instructions for timing and how to take it.

What if I forget a dose?
Take it as soon as you remember, unless it is almost time for the next dose. If it is close to your next dose, skip the missed one. Do not take two tablets to catch up. An occasional missed dose will not ruin your treatment, but try to be consistent.

Delivery Information Across Canada

We ship Femara and generic letrozole to all provinces and territories. Delivery times vary depending on how remote your location is:

• Ontario (Toronto, Ottawa, Mississauga): 5 to 7 days
• Quebec (Montreal, Quebec City, Laval): 5 to 7 days
• British Columbia (Vancouver, Victoria, Burnaby): 5 to 9 days
• Alberta (Calgary, Edmonton, Red Deer): 5 to 9 days
• Manitoba (Winnipeg, Brandon): 5 to 9 days
• Saskatchewan (Saskatoon, Regina): 5 to 9 days
• Nova Scotia (Halifax, Sydney): 5 to 9 days
• New Brunswick (Moncton, Fredericton): 5 to 9 days
• Newfoundland and Labrador (St. John's, Corner Brook): 7 to 14 days
• Prince Edward Island (Charlottetown): 7 to 14 days
• Yukon, Northwest Territories, Nunavut: 7 to 14 days

All shipments are packed discreetly with no branding or indication of contents on the outside.

How to buy Generic Femara (Letrozole) no prescription from Canadian Pharmacy.